Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Can we say sub 4

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon May 11, 2021 10:07pm

168 Views

Post# 33180235

RE:RE:RE:RE:RE:Can we say sub 4

What can I say, you’re rubbing off on all of us Jizz-a. I’ll watch watch you eat your words like dumpster lol

YukonJezza wrote:

Inthepez wrote: Idk between you and dumpster it’s hard to tell sometimes lol! Eh Coooooock cheese

YukonJezza wrote:

Inthepez wrote: Can we say dipsh!!t lol

M

YukonJezza wrote:

yes we will see who the dipshit is.!

muffin, that's very unbecoming of you. See you at 3.56 ilikepizz